N.º de artículoCLM-8065-PK

L-Malic acid (¹³C₄, 99%)

Sinónimos(2S)-2-Hydroxybutanedioic acid; l-Malic acid; Apple acid; (-)-Malic acid
FórmulaHO2*C*CH2*CH(OH)*CO2H
CAS Número LebeledNA
CAS Número Unlabeled97-67-6
Número CE202-601-5 (Unlabeled)

Propiedades

Peso molecular138.06
Pureza98%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics, MS/MS Standards
Temperatura de almacenamientoStore at room temperature away from light and moisture.

Descripción

Product Description
L-Malic acid (13C4) is an organic dicarboxylic acid that is present in various foods and is metabolized in humans through the Krebs (or citric acid) cycle. In its stable isotope-labeled form, it is commonly used as an authentic standard for metabolite quantification.
Application(s)

Información de seguridad

Hazard Pictograms
HazardousImage
Signal WordWarning
Hazard StatementCauses skin irritation., Causes serious eye irritation., May cause respiratory irritation.

Comentarios (0)

Todavía no hay comentarios.

N.º de artículoCLM-8065-PK

L-Malic acid (¹³C₄, 99%)

No description
Sinónimos(2S)-2-Hydroxybutanedioic acid; l-Malic acid; Apple acid; (-)-Malic acid
FórmulaHO2*C*CH2*CH(OH)*CO2H
CAS Número LebeledNA
CAS Número Unlabeled97-67-6
Número CE202-601-5 (Unlabeled)

Propiedades

Peso molecular138.06
Pureza98%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics, MS/MS Standards
Temperatura de almacenamientoStore at room temperature away from light and moisture.

Descripción

Product Description
L-Malic acid (13C4) is an organic dicarboxylic acid that is present in various foods and is metabolized in humans through the Krebs (or citric acid) cycle. In its stable isotope-labeled form, it is commonly used as an authentic standard for metabolite quantification.
Application(s)

Información de seguridad

Hazard Pictograms
HazardousImage
Signal WordWarning
Hazard StatementCauses skin irritation., Causes serious eye irritation., May cause respiratory irritation.

Comentarios (0)

Todavía no hay comentarios.